Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1417)
- Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains. (2018/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. MALT lymphoma arising on a background of reactive pulmonary lymphoid hyperplasia in a patient with systemic lupus erythematosus. (2018/03/01) ♡
- Cardiac amyloidosis is associated with increased aortic stiffness. (2018/03/01) ♡
- Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity? (2018/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. (2018/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coronary ectasia in amyloid cardiomyopathy and neuropathy due to the transthyretin mutation c.323A>G. (2018/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis. (2018/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute heart failure by senile systemic amyloidosis: Case report. (2018/02/23) ♡
- Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis. (2018/02/23) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Apical to Base Gradient of Technetium-99m Pyrophosphate Myocardial Counts in Cardiac Amyloidosis: An Insight Into the Mechanism of Myocardial Strain Gradient, or Merely "Clouds That Mimic Land Before the Sailor's Eye?". (2018/02/01) ♡
- Predictors of survival stratification in patients with wild-type cardiac amyloidosis. (2018/02/01) ♡
- Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies. (2018/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in diagnosis and treatment of cardiac amyloidosis. (2018/02/01) ♡
- Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis. (2018/02/01) ♡
- Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan. (2018/01/15) ♡
- Differential associations between retinal signs and CMBs by location: The AGES-Reykjavik Study. (2018/01/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac disease in familial Mediterranean fever. (2018/01/01) ♡
- Abnormal Coronary Flow Velocity Reserve and Decreased Myocardial Contractile Reserve Are Main Factors in Relation to Physical Exercise Capacity in Cardiac Amyloidosis. (2018/01/01) ♡
- Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. (2018/01/01) ♡
- Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide. (2018/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Foreword. (2018/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions. (2018/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy. (2018/01/01) ♡
- [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis]. (2018/01/01) ♡
- Total 12-Lead QRS Voltage in Patients Having Orthotopic Heart Transplantation for Heart Failure Caused by Adriamycin-Induced Cardiomyopathy. (2018/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sahlgrenska Cardiomyopathy Project (2018-11-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects (2018-10-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) (2018-07-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. DD2-Coronary Plaque Morphology and Plaque Progression (2018-05-08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease (2018-03-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis (2018-03-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering (2018-02-13) ♡
- Impaired right ventricular function as a predictor of early mortality in patients with light-chain cardiac amyloidosis assessed in a cardiology department. (2017/12/22) ♡
- Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis. (2017/12/19) ♡
- Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. (2017/12/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation. (2017/12/01) ♡
- Predictors of Prognosis in Light-Chain Amyloidosis and Chronological Changes in Cardiac Morphology and Function. (2017/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment. (2017/12/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study. (2017/12/01) ♡
- Misidentification of transthyretin and immunoglobulin variants by proteomics due to methyl lysine formation in formalin-fixed paraffin-embedded amyloid tissue. (2017/12/01) ♡
- The value of endomyocardial biopsy in diagnosis and guiding therapy. (2017/12/01) ♡
- Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage. (2017/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiovascular complications of multiple myeloma in the elderly. (2017/12/01) ♡
- Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity. (2017/12/01) ♡
- Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Temporary Biventricular Assist Device to Bridge a Patient With Cardiogenic Shock Due to AL Amyloidosis to Heart Transplantation. (2017/12/01) ♡
- Left atrial dysfunction in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy - A comparative three-dimensional speckle-tracking echocardiographic analysis from the MAGYAR-Path Study. (2017/12/01) ♡
- Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac amyloidosis: An update on diagnosis and treatment. (2017/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.